vs
Side-by-side financial comparison of Innovative Eyewear Inc (LUCY) and RxSight, Inc. (RXST). Click either name above to swap in a different company.
RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $959.8K, roughly 34.0× Innovative Eyewear Inc). RxSight, Inc. runs the higher net margin — -28.1% vs -194.8%, a 166.8% gap on every dollar of revenue. On growth, Innovative Eyewear Inc posted the faster year-over-year revenue change (39.0% vs -18.9%). Innovative Eyewear Inc produced more free cash flow last quarter ($-1.4M vs $-2.3M). Over the past eight quarters, Innovative Eyewear Inc's revenue compounded faster (58.2% CAGR vs 5.1%).
General Eyewear is a London-based eyewear company and brand. The company was founded in the late 1990s by Fraser Laing. Originally under the name Arckiv, it produced its own original eyewear designs and had a particular specialism in vintage eyewear.
RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.
LUCY vs RXST — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $959.8K | $32.6M |
| Net Profit | $-1.9M | $-9.2M |
| Gross Margin | 12.0% | 77.5% |
| Operating Margin | — | -34.8% |
| Net Margin | -194.8% | -28.1% |
| Revenue YoY | 39.0% | -18.9% |
| Net Profit YoY | 12.0% | -54.1% |
| EPS (diluted) | $-0.14 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $959.8K | $32.6M | ||
| Q3 25 | $668.1K | $30.3M | ||
| Q2 25 | $579.2K | $33.6M | ||
| Q1 25 | $454.5K | $37.9M | ||
| Q4 24 | $690.7K | $40.2M | ||
| Q3 24 | $253.6K | $35.3M | ||
| Q2 24 | $308.7K | $34.9M | ||
| Q1 24 | $383.5K | $29.5M |
| Q4 25 | $-1.9M | $-9.2M | ||
| Q3 25 | $-1.8M | $-9.8M | ||
| Q2 25 | $-2.1M | $-11.8M | ||
| Q1 25 | $-1.8M | $-8.2M | ||
| Q4 24 | $-2.1M | $-5.9M | ||
| Q3 24 | $-1.7M | $-6.3M | ||
| Q2 24 | $-1.9M | $-6.1M | ||
| Q1 24 | $-2.0M | $-9.1M |
| Q4 25 | 12.0% | 77.5% | ||
| Q3 25 | 36.6% | 79.9% | ||
| Q2 25 | -2.2% | 74.9% | ||
| Q1 25 | 48.5% | 74.8% | ||
| Q4 24 | 13.6% | 71.6% | ||
| Q3 24 | 23.4% | 71.4% | ||
| Q2 24 | 17.9% | 69.5% | ||
| Q1 24 | 1.8% | 70.1% |
| Q4 25 | — | -34.8% | ||
| Q3 25 | — | -40.1% | ||
| Q2 25 | — | -41.6% | ||
| Q1 25 | — | -28.2% | ||
| Q4 24 | — | -21.5% | ||
| Q3 24 | — | -26.1% | ||
| Q2 24 | — | -23.9% | ||
| Q1 24 | — | -36.2% |
| Q4 25 | -194.8% | -28.1% | ||
| Q3 25 | -274.8% | -32.4% | ||
| Q2 25 | -363.6% | -35.0% | ||
| Q1 25 | -391.4% | -21.6% | ||
| Q4 24 | -307.8% | -14.8% | ||
| Q3 24 | -678.5% | -17.9% | ||
| Q2 24 | -631.2% | -17.4% | ||
| Q1 24 | -514.1% | -30.8% |
| Q4 25 | $-0.14 | $-0.22 | ||
| Q3 25 | $-0.38 | $-0.24 | ||
| Q2 25 | $-0.66 | $-0.29 | ||
| Q1 25 | $-0.72 | $-0.20 | ||
| Q4 24 | $0.26 | $-0.14 | ||
| Q3 24 | $-0.99 | $-0.16 | ||
| Q2 24 | $-1.87 | $-0.16 | ||
| Q1 24 | $-2.59 | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.5M | $228.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $9.1M | $275.7M |
| Total Assets | $10.1M | $311.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.5M | $228.1M | ||
| Q3 25 | $6.7M | $227.5M | ||
| Q2 25 | $7.6M | $227.5M | ||
| Q1 25 | $5.3M | $229.3M | ||
| Q4 24 | $2.6M | $237.2M | ||
| Q3 24 | $4.5M | $237.1M | ||
| Q2 24 | $5.9M | $233.3M | ||
| Q1 24 | $2.6M | $125.4M |
| Q4 25 | $9.1M | $275.7M | ||
| Q3 25 | $10.3M | $276.0M | ||
| Q2 25 | $11.3M | $278.0M | ||
| Q1 25 | $7.5M | $279.3M | ||
| Q4 24 | $9.1M | $281.2M | ||
| Q3 24 | $10.9M | $277.3M | ||
| Q2 24 | $7.3M | $275.2M | ||
| Q1 24 | $3.9M | $163.9M |
| Q4 25 | $10.1M | $311.8M | ||
| Q3 25 | $11.2M | $308.5M | ||
| Q2 25 | $11.9M | $309.0M | ||
| Q1 25 | $7.9M | $313.0M | ||
| Q4 24 | $9.8M | $318.6M | ||
| Q3 24 | $11.6M | $310.5M | ||
| Q2 24 | $7.9M | $305.5M | ||
| Q1 24 | $4.8M | $183.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.4M | $-1.1M |
| Free Cash FlowOCF − Capex | $-1.4M | $-2.3M |
| FCF MarginFCF / Revenue | -142.5% | -6.9% |
| Capex IntensityCapex / Revenue | 1.8% | 3.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.4M | $-1.1M | ||
| Q3 25 | $-1.5M | $-1.2M | ||
| Q2 25 | $-2.1M | $-4.4M | ||
| Q1 25 | $-2.3M | $-8.8M | ||
| Q4 24 | $-1.9M | $-4.3M | ||
| Q3 24 | $-1.4M | $650.0K | ||
| Q2 24 | $-1.9M | $-4.0M | ||
| Q1 24 | $-1.5M | $-9.3M |
| Q4 25 | $-1.4M | $-2.3M | ||
| Q3 25 | $-1.5M | $-1.8M | ||
| Q2 25 | — | $-5.9M | ||
| Q1 25 | $-2.4M | $-9.4M | ||
| Q4 24 | $-2.0M | $-5.1M | ||
| Q3 24 | — | $-453.0K | ||
| Q2 24 | $-1.9M | $-5.5M | ||
| Q1 24 | $-1.5M | $-11.3M |
| Q4 25 | -142.5% | -6.9% | ||
| Q3 25 | -226.3% | -5.8% | ||
| Q2 25 | — | -17.6% | ||
| Q1 25 | -517.4% | -24.8% | ||
| Q4 24 | -285.2% | -12.7% | ||
| Q3 24 | — | -1.3% | ||
| Q2 24 | -626.1% | -15.9% | ||
| Q1 24 | -391.1% | -38.2% |
| Q4 25 | 1.8% | 3.5% | ||
| Q3 25 | 2.2% | 1.9% | ||
| Q2 25 | 0.0% | 4.6% | ||
| Q1 25 | 8.9% | 1.5% | ||
| Q4 24 | 3.8% | 2.1% | ||
| Q3 24 | 0.0% | 3.1% | ||
| Q2 24 | 1.1% | 4.4% | ||
| Q1 24 | 8.4% | 6.7% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LUCY
Segment breakdown not available.
RXST
| Rxlal | $28.2M | 86% |
| LDD | $3.0M | 9% |
| Service Warranty Service Contracts And Accessories | $1.5M | 4% |
